EMvision Medical Devices Ltd.ASX: EMV

Key Developments in Pivotal Trial & Innovation Study

· Issued by EMvision Medical Devices Ltd.

Filed with ASX · · 4 pages · English

Summary by 6ix AI

EMvision Medical Devices Ltd. provides an update on its Pivotal Trial and Continuous Innovation Study for its emu™ bedside brain scanner. Five of the six trial sites are now actively enrolling and scanning patients, with the sixth site preparation underway. The company has also received approval to start a Continuous Innovation Study at two hospitals in Australia. This study aims to enhance device innovation and support indication expansion for traumatic brain injury.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

EMvision Medical Devices Ltd. on 6ix

Story so far

Earlier from EMvision Medical Devices

Later from EMvision Medical Devices

All EMvision Medical Devices news releases